Total Payments
$48,272
2024 Payments
$1,742
Companies
45
Transactions
510
Medicare Patients
14,791
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$27,060 (56.1%)
Food & Beverage$13,965 (28.9%)
Consulting$4,180 (8.7%)
Travel$2,411 (5.0%)
Education$656.10 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23,710 | 11 | 49.1% |
| Food and Beverage | $13,965 | 464 | 28.9% |
| Consulting Fee | $4,180 | 2 | 8.7% |
| Honoraria | $3,350 | 2 | 6.9% |
| Travel and Lodging | $2,411 | 17 | 5.0% |
| Education | $656.10 | 14 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $31,683 | 99 | $0 (2024) |
| EPI Health, LLC | $3,094 | 4 | $0 (2018) |
| ABBVIE INC. | $2,636 | 74 | $0 (2024) |
| UCB, Inc. | $1,436 | 26 | $0 (2023) |
| Janssen Biotech, Inc. | $1,383 | 45 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,150 | 38 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $696.34 | 19 | $0 (2023) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $489.49 | 11 | $0 (2020) |
| Biofrontera Inc. | $475.00 | 2 | $0 (2018) |
| Lilly USA, LLC | $420.44 | 19 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,742 | 50 | Janssen Biotech, Inc. ($457.58) |
| 2023 | $3,523 | 67 | UCB, Inc. ($1,229) |
| 2022 | $904.66 | 41 | ABBVIE INC. ($233.83) |
| 2021 | $3,436 | 22 | Novartis Pharmaceuticals Corporation ($3,015) |
| 2020 | $598.13 | 22 | AbbVie Inc. ($158.09) |
| 2019 | $12,508 | 118 | Novartis Pharmaceuticals Corporation ($9,935) |
| 2018 | $17,953 | 100 | Novartis Pharmaceuticals Corporation ($15,868) |
| 2017 | $7,608 | 90 | EPI Health, LLC ($3,066) |
All Payment Transactions
510 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Immunology | ||||||
| 11/14/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $107.65 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $123.47 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Inflammation | ||||||
| 09/16/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Immunology | ||||||
| 09/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.03 | General |
| Category: Immunology | ||||||
| 09/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Immunology | ||||||
| 08/28/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.02 | General |
| Category: Immunology | ||||||
| 08/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: ANTIBIOTIC | ||||||
| 08/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Dermatology | ||||||
| 08/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Immunology | ||||||
| 07/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Education | In-kind items and services | $85.00 | General |
| 07/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Dermatology | ||||||
| 07/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: IMMUNOLOGY | ||||||
| 07/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: IMMUNOLOGY | ||||||
| 06/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $30.28 | General |
| Category: Dermatology | ||||||
| 06/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Dermatology | ||||||
| 06/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 3,637 | 5,808 | $597,985 | $259,064 |
| 2022 | 18 | 3,757 | 6,139 | $662,470 | $293,387 |
| 2021 | 20 | 4,285 | 6,797 | $750,470 | $333,839 |
| 2020 | 18 | 3,112 | 4,458 | $467,225 | $184,314 |
Total Patients
14,791
Total Services
23,202
Medicare Billing
$1.1M
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 895 | 1,223 | $128,415 | $71,463 | 55.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 514 | 682 | $109,120 | $56,733 | 52.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 450 | 545 | $81,750 | $41,600 | 50.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 351 | 397 | $63,520 | $23,485 | 37.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 506 | 637 | $76,440 | $20,812 | 27.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 58 | 71 | $24,850 | $8,551 | 34.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 130 | 218 | $17,440 | $7,690 | 44.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 166 | 185 | $13,875 | $6,975 | 50.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 324 | 1,503 | $45,120 | $6,684 | 14.8% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 40 | 46 | $8,970 | $4,098 | 45.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 31 | 35 | $6,300 | $2,956 | 46.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $7,150 | $2,730 | 38.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $6,290 | $2,011 | 32.0% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 26 | 26 | $3,510 | $973.16 | 27.7% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 14 | 19 | $1,710 | $788.38 | 46.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 78 | $1,170 | $788.25 | 67.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 17 | 18 | $1,620 | $592.31 | 36.6% |
| Q0112 | All potassium hydroxide (koh) preparations | Office | 2023 | 16 | 17 | $255.00 | $97.07 | 38.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 25 | 48 | $480.00 | $35.15 | 7.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 829 | 1,189 | $124,845 | $72,919 | 58.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 582 | 777 | $124,320 | $64,593 | 52.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 476 | 613 | $91,950 | $48,800 | 53.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 403 | 488 | $78,080 | $30,725 | 39.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 510 | 660 | $79,200 | $21,426 | 27.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 157 | 263 | $21,040 | $9,869 | 46.9% |
About Dr. Marta Hampton, MD
Dr. Marta Hampton, MD is a Dermatopathology healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952403446.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marta Hampton, MD has received a total of $48,272 in payments from pharmaceutical and medical device companies, with $1,742 received in 2024. These payments were reported across 510 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($23,710).
As a Medicare-enrolled provider, Hampton has provided services to 14,791 Medicare beneficiaries, totaling 23,202 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Location Charleston, SC
- Active Since 09/04/2006
- Last Updated 07/08/2007
- Taxonomy Code 207ND0900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952403446
Products in Payments
- COSENTYX (Biological) $31,477
- Bensal HP (Drug) $3,094
- TREMFYA (Drug) $1,118
- Humira (Biological) $750.27
- ILUMYA (Biological) $583.16
- Otezla (Drug) $578.72
- SKYRIZI (Biological) $557.88
- DUPIXENT (Biological) $546.11
- Ameluz (Drug) $475.00
- DUPIXENT DUPILUMAB INJECTION (Biological) $419.54
- RINVOQ (Biological) $389.08
- VTAMA (Drug) $382.07
- TALTZ (Drug) $333.85
- Sotyktu (Drug) $269.34
- EUCRISA (Drug) $240.72
- OPZELURA (Drug) $236.93
- Cimzia (Drug) $228.34
- Skyrizi (Biological) $222.44
- COSENTYX (Drug) $205.96
- Erivedge (Biological) $204.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatopathology Doctors in Charleston
Dr. John Maize, Md, MD
Dermatopathology — Payments: $11,763
Dermatopathology $11,763
David Perry, M.d, M.D
Dermatopathology — Payments: $3,787
Dermatopathology $3,787
Dr. John Maize, Md, MD
Dermatopathology — Payments: $1,665
Dermatopathology $1,665
Dr. Graciela De Jesus, Md, MD
Dermatopathology
Dermatopathology